96082-28-9

Upstream product

• 87376-56-5 1-Acetyl-2-azido-4,6-di-O-benzoyl-2-desoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-O-α-D-galactopyranose 
• 87376-57-6 2-azido-4,6-di-O-benzoyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-α-D-galactopyranosyl bromide 
• 21209-51-8 N-benzyloxycarbonyl-L-serine benzyl ester 
• 108-24-7 acetic anhydride 

Downstream Products

• 96031-31-1 3-O-<2-Acetamido-4,6-di-O-benzoyl-2-desoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-α-D-galactopyranosyl>-L-serin 
• 60280-57-1 3-O-(2-acetamido-2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranosyl)-L-serine 

Relevant academic research and scientific papers

BLOCKSYNTHESE VON O-GLYCOPEPTIDEN UND ANDEREN T-ANTIGEN STRUKTUREN

Under the conditions of in situ anomerisation, the 2-azido-4,6-di-O-benzoyl-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-α-D-galactopyranosyl bromide reacted directly and with high selectivity with the reactive hydroxyl groups of L-serine and L-threonine derivatives to form α-glycosidically-linked products.Thus, the glycopeptides containing L-serine and L-threonine are more accessible.The disaccharide block could also be coupled with other reactive hydroxyl compounds to give compounds that contain the T-receptor.